CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 63 filers reported holding CYTOMX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $154,695 | -24.8% | 119,919 | +0.3% | 0.00% | – |
| Q2 2023 | $205,736 | +13.5% | 119,614 | -0.3% | 0.00% | – |
| Q1 2023 | $181,200 | +0.7% | 120,000 | +6.7% | 0.00% | – |
| Q4 2022 | $179,888 | +10.4% | 112,430 | 0.0% | 0.00% | – |
| Q3 2022 | $163,000 | -20.9% | 112,430 | -0.0% | 0.00% | – |
| Q2 2022 | $206,000 | -86.5% | 112,482 | -80.4% | 0.00% | – |
| Q1 2022 | $1,531,000 | -42.5% | 573,435 | -6.8% | 0.00% | – |
| Q4 2021 | $2,664,000 | -20.1% | 615,321 | -6.0% | 0.00% | -100.0% |
| Q3 2021 | $3,333,000 | -21.0% | 654,686 | -1.8% | 0.00% | 0.0% |
| Q2 2021 | $4,220,000 | -20.3% | 666,474 | -2.7% | 0.00% | 0.0% |
| Q1 2021 | $5,295,000 | +54.1% | 684,925 | +30.6% | 0.00% | 0.0% |
| Q4 2020 | $3,435,000 | -2.6% | 524,551 | -1.1% | 0.00% | 0.0% |
| Q3 2020 | $3,527,000 | -25.6% | 530,384 | -6.8% | 0.00% | 0.0% |
| Q2 2020 | $4,741,000 | +7.4% | 569,070 | -1.1% | 0.00% | 0.0% |
| Q1 2020 | $4,413,000 | -5.2% | 575,420 | +2.7% | 0.00% | 0.0% |
| Q4 2019 | $4,656,000 | +12.9% | 560,450 | +0.3% | 0.00% | 0.0% |
| Q3 2019 | $4,123,000 | -32.7% | 558,720 | +2.3% | 0.00% | 0.0% |
| Q2 2019 | $6,127,000 | +5.1% | 546,078 | +0.7% | 0.00% | 0.0% |
| Q1 2019 | $5,827,000 | -28.5% | 542,020 | +0.4% | 0.00% | -50.0% |
| Q4 2018 | $8,154,000 | -18.4% | 539,989 | -0.1% | 0.00% | 0.0% |
| Q3 2018 | $9,998,000 | -0.4% | 540,412 | +23.1% | 0.00% | -33.3% |
| Q2 2018 | $10,039,000 | +9.2% | 439,134 | +35.9% | 0.00% | +50.0% |
| Q1 2018 | $9,190,000 | +34.7% | 323,015 | -0.1% | 0.00% | 0.0% |
| Q4 2017 | $6,822,000 | +13.9% | 323,182 | -1.9% | 0.00% | 0.0% |
| Q3 2017 | $5,987,000 | +22.0% | 329,511 | +4.1% | 0.00% | +100.0% |
| Q2 2017 | $4,907,000 | +22.5% | 316,586 | +36.5% | 0.00% | 0.0% |
| Q1 2017 | $4,006,000 | +55.5% | 231,984 | -1.1% | 0.00% | 0.0% |
| Q4 2016 | $2,577,000 | -24.0% | 234,506 | +8.4% | 0.00% | 0.0% |
| Q3 2016 | $3,391,000 | +232.8% | 216,324 | +116.8% | 0.00% | – |
| Q2 2016 | $1,019,000 | +7.2% | 99,772 | +35.3% | 0.00% | – |
| Q1 2016 | $951,000 | -38.0% | 73,717 | +0.4% | 0.00% | -100.0% |
| Q4 2015 | $1,533,000 | – | 73,459 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,803,700 | $25,130,000 | 0.91% |
| Altium Capital Management LP | 663,800 | $2,874,000 | 0.79% |
| Rubric Capital Management LP | 2,406,449 | $10,420,000 | 0.49% |
| RTW INVESTMENTS, LP | 6,029,700 | $26,109,000 | 0.38% |
| Orbimed Advisors | 3,214,509 | $13,919,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 152,345 | $660,000 | 0.13% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 980,085 | $4,244,000 | 0.12% |
| Point72 Asset Management, L.P. | 6,303,025 | $27,292,000 | 0.11% |
| Sender Co & Partners, Inc. | 40,720 | $176,000 | 0.09% |
| Manteio Capital LLC | 15,067 | $65,000 | 0.08% |